{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T07:11:50Z","timestamp":1693897910783},"reference-count":0,"publisher":"AME Publishing Company","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann. Transl. Med."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.21037\/atm.2017.08.43","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T07:45:46Z","timestamp":1512632746000},"page":"455-455","source":"Crossref","is-referenced-by-count":6,"title":["Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes"],"prefix":"10.21037","volume":"5","author":[{"given":"Wilbert S.","family":"Aronow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana A.","family":"Shamliyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8611","published-online":{"date-parts":[[2017,12]]},"container-title":["Annals of Translational Medicine"],"original-title":[],"link":[{"URL":"http:\/\/atm.amegroups.com\/article\/download\/16856\/17183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T07:45:47Z","timestamp":1512632747000},"score":1,"resource":{"primary":{"URL":"http:\/\/atm.amegroups.com\/article\/view\/16856\/17848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":0,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2017,12]]},"published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.21037\/atm.2017.08.43","relation":{},"ISSN":["2305-5839","2305-5847"],"issn-type":[{"value":"2305-5839","type":"print"},{"value":"2305-5847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}